Weight loss drug Wegovy to be subsidised for Australians with severe obesity

An Ozempic-like medication is set to be listed on the Pharmaceutical Benefits Scheme shortly, saving patients with “severe” obesity and cardiovascular disease thousands of dollars even as the government warns it will lump taxpayers with a “very…

Continue Reading